| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.1780210608 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780210608 |
| https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.1780210608 | ||
| P698 | PubMed publication ID | 153749 |
| P2093 | author name string | I. Green | |
| A. D. Steinberg | |||
| T. Sakane | |||
| P2860 | cites work | Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active sle | Q28324175 |
| Lymphocyte Function in Rheumatic Disorders | Q34041651 | ||
| Hodgkin's disease. An immunodepleting and immunosuppressive disorder | Q35195598 | ||
| Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus | Q35198438 | ||
| AUTOANTIBODIES AND DISEASE. | Q35525242 | ||
| Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus | Q35569371 | ||
| Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus | Q35905494 | ||
| Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus | Q35982310 | ||
| Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors | Q36359299 | ||
| Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes | Q36359334 | ||
| Loss of suppressor T cells in adult NZB/NZW mice | Q36359846 | ||
| Viruses and Systemic Lupus Erythematosus | Q36456384 | ||
| Selective loss of suppressor cell function in New Zealand mice induced by NTA | Q39160640 | ||
| Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus | Q39317182 | ||
| C-Type Virus Expression in Systemic Lupus Erythematosus | Q40003429 | ||
| Prevention of autoimmunity in experimental lupus erythematosus by soluble immune response suppressor | Q40642426 | ||
| Induction of Suppressor T Cells in Systemic Lupus Erythematosus by Thymosin and Cultured Thymic Epithelium | Q40652709 | ||
| Human suppressor T cells induced by concanavalin A: suppressor T cells belong to distinctive T cell subclasses | Q40654205 | ||
| Suppressor thymus-derived lymphocytes in fungal infection | Q40982375 | ||
| Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity | Q41840807 | ||
| Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions | Q42927196 | ||
| Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus | Q43434511 | ||
| Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia | Q44102847 | ||
| Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells | Q66878960 | ||
| Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus | Q66887430 | ||
| A relationship between impaired cellular immunity, humoral suppression of lymphocyte function and severity of systemic lupus erythematosus | Q66941484 | ||
| Relative T-Cell Specificity of Lymphocytotoxins from Patients with Systemic Lupus Erythematosus | Q69264476 | ||
| Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte culture | Q70020323 | ||
| Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes | Q70559027 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| rheumatology | Q327657 | ||
| immunology | Q101929 | ||
| P304 | page(s) | 657-664 | |
| P577 | publication date | 1978-07-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| Arthritis and Rheumatism | Q23929027 | ||
| P1476 | title | Studies of immune functions of patients with systemic lupus erythematosus. i. dysfunction of suppressor t‐cell activity related to impaired generation of, rather than response to, suppressor cells | |
| P478 | volume | 21 |
| Q37695062 | A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum |
| Q34563462 | A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody |
| Q40159025 | Abnormalities of immune regulation in the connective tissue diseases |
| Q67296668 | Alteration of Fc-receptor phenotype and proliferative capacity of Fc-IgG-receptor positive lymphocytes through interaction with soluble immune complexes of patients with SLE or RA |
| Q37025065 | Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus |
| Q39639039 | Alterations of the immune system in ulcerative colitis and Crohn's disease. |
| Q72432481 | Altered suppressor-cell activities in uveitis |
| Q36998593 | Animal models of human systemic lupus erythematosus |
| Q36996129 | Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells |
| Q36996580 | Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis |
| Q47204934 | B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor |
| Q40116520 | BCG-induced macrophages as suppressor cells |
| Q40393908 | Bcl-2 and Fas, molecules which influence apoptosis. A possible role in systemic lupus erythematosus? |
| Q72755944 | Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome |
| Q39423992 | Cell-mediated immunity in gastrointestinal disease |
| Q39728083 | Cell-mediated immunity in rheumatic disease |
| Q40113022 | Cellular mechanism of tissue injury and immune derangement in systemic lupus erythematosus |
| Q58205101 | Cellular regulation of anti-nRNP antibody synthesis is different from that of anti-DNA antibody synthesis in patients with systemic lupus erythematosus |
| Q72759768 | Characterization of human peripheral blood T lymphocytes bearing receptors for autologous erythrocytes and T lymphocytes lacking these receptors |
| Q35609787 | Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus |
| Q40117195 | Circulating immune complexes: Their immunochemistry, biology, and detection in selected dermatologic and systemic diseases |
| Q52218583 | Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML |
| Q72773555 | Con A induced suppressor test: an evaluation of the experimental conditions |
| Q41925914 | Concanavalin A-induced suppressor cell activity and in vitro immunoglobulin secretion in rheumatoid arthritis: Correlation with clinical and immunological parameters |
| Q40075855 | Contrasuppression: the second law of thymodynamics, revisited |
| Q38704398 | Conversion of systemic lupus erythematosus to common variable hypogammaglobulinemia |
| Q72761013 | Decreased Syngeneic Mixed Lymphocyte Reaction in Autoimmune Susceptible Mice |
| Q72761862 | Depressed functions of T cells and the presence of suppressor macrophages in patients with sarcoidosis |
| Q39573126 | Detection of Antilymphocyte Antibody with Two-Color Method in Systemic Lupus Erythematosus and Its Heterogeneous Specificities against Human T-Cell Subsets |
| Q71007119 | Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases |
| Q39876714 | Differential sensitivity of functional subsets of t cells to the cytotoxicity of natural t-lymphocytotoxic autoantibody of systemic lupus erythematosus |
| Q40734892 | Disease activity in systemic lupus erythematosus value of laboratory criteria |
| Q70568500 | Effects of methyl-B12 on the in vitro immune functions of human T lymphocytes |
| Q40722955 | Erythrocyte rosette inhibition as an assay for naturally occurring t lymphocytotoxic antibody in systemic lupus erythematosus |
| Q34183981 | Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow |
| Q37591170 | Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus |
| Q40721784 | Familial Abnormalities of Suppressor-Cell Function in Systemic Lupus Erythematosus |
| Q72753728 | Functional analysis of the defective T cell regulation of the antigen-specific PFC response in SLE patients: differentiation of suppressor precursor cells to suppressor effector cells |
| Q40984538 | Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique |
| Q70999465 | Generation of a soluble immune response suppressor factor (IRSF) by unstimulated leukocytes of healthy subjects |
| Q52224265 | Generation of suppressor cells in the autologous mixed lymphocyte reaction. |
| Q40218886 | Genetic and immune aspects of systemic lupus erythematosus |
| Q72672698 | Genetic, environmental, and cellular factors in the pathogenesis of systemic lupus erythematosus |
| Q39139639 | Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus |
| Q41151962 | Human CD8+ lymphocytes stimulated in the absence of CD4+ cells enhance IgG production by antibody-secreting B cells |
| Q93631796 | Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies |
| Q68084318 | Identification and characterization of IgA and Vicia villosa-binding T cell subsets in rheumatoid arthritis |
| Q70540779 | Immune regulation in inflammatory bowel disease: absence of a serum inhibitor of suppressor cell function |
| Q72761581 | Immune responses to hapten-modified self and their regulation in normal individuals and patients with systemic lupus erythematosus |
| Q71585130 | Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity |
| Q33645166 | Immunological abnormalities in patients with untreated retinal vasculitis |
| Q37020805 | Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations |
| Q33485548 | Immunoregulatory abnormalities in children with thrombocytopenic purpura |
| Q36992405 | Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte |
| Q72611531 | Impaired antigen-specific suppressor cell activity in patients with systemic lupus erythematosus |
| Q72789635 | Impaired autologous mixed lymphocyte reaction with normal concanavalin A-induced suppression in adult polymyositis/dermatomyositis |
| Q35207072 | In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus |
| Q44593195 | Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis. |
| Q54436319 | Increased thymic hormone responsive suppressor T lymphocyte function in chronic active hepatitis |
| Q72619957 | Induction of nonspecific, proliferative dependent, suppressor T lymphocytes in human mixed lymphocyte cultures |
| Q67562812 | Influence of prolonged neuropsychological testing on immunoregulatory cells and hormonal parameters in patients with systemic lupus erythematosus |
| Q33553985 | Inhibition of proliferative and suppressor responses in the autologous mixed lymphocyte reaction by serum from patients with systemic lupus erythematosus |
| Q34621296 | Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus |
| Q72669967 | Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus |
| Q68093097 | Interactions of IgG from SLE patients with peripheral blood mononuclear cells and adherent cell populations |
| Q40714863 | Lack of suppressor cell activity in systemic lupus erythematosus |
| Q58378030 | Myasthenia gravis with a monoclonal gammopathy |
| Q36998426 | Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus |
| Q39467961 | Phenotypic and functional characterization of human contrasuppressor cell interactions |
| Q41359034 | Phenotypic expression of Vicia villosa binding T cell subsets, as markers of contrasuppressor cells in systemic lupus erythematosus |
| Q72671625 | Reduced Natural Killer Cell Activity of Lymphocytes from Patients with Werner's Syndrome and Recovery of Its Activity by Purified Human Leucocyte Interferon |
| Q69986312 | Reduced function of HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE) |
| Q72761893 | Reevaluation of suppressor cell function in systemic lupus erythematosus |
| Q34605215 | Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions |
| Q39826041 | Screening Tests for Cell-Mediated Immunodeficiency Diseases |
| Q39384694 | Serum lymphocytotoxic activity in leprosy. |
| Q72761875 | Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type |
| Q69045037 | Specific suppression of anti-DNA production in vitro |
| Q41832222 | Spontaneous and Concanavalin A-induced suppressor activity in control and Hodgkin's disease patients |
| Q39886956 | Studies of immune functions of patients with systemic lupus erythematosus |
| Q37038182 | Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells |
| Q37017080 | Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets |
| Q36982582 | Studies of immune functions of patients with systemic lupus erythematosus: antibodies to desialized, rather than intact, T cells preferentially bind to and eliminate suppressor effector T cells |
| Q70564050 | Studies on T cell subsets and functions in leprosy |
| Q70534061 | Studies on the suppression of a one-way mixed lymphocyte reaction by mitomycin-C treated responder cells |
| Q33552775 | Subpopulations of T lymphocytes in patients with ankylosing spondylitis |
| Q70527972 | Suppressor cell defect in SLE: relationship to native DNA binding |
| Q39899025 | Suppressor cell function defect in idiopathic systemic lupus erythematosus |
| Q37036829 | Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction |
| Q40721789 | Systemic Lupus Erythematosus, Autoimmunity, Sex and Inheritance |
| Q36982829 | T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus |
| Q40720292 | T lymphocyte subpopulations in synovial fluid of patients with rheumatic disease |
| Q40219367 | The autologous mixed-lymphocyte reaction. |
| Q34731092 | Therapy of systemic lupus erythematosus: a look into the future |
| Q64389051 | Urinary loss of immunoglobulin G anti-F(ab)2 and anti-DNA antibody in systemic lupus erythematosus nephritis |
Search more.